- Company Directors - L
- Lichtinger Pedro
Insider Trading History of Lichtinger Pedro
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lichtinger Pedro since 2011.
The trader's CIK number is 1470741.
At the time of the last reporting, Lichtinger Pedro was the CEO and President of Gemphire Therapeutics Inc.. (stock ticker symbol GEMP).
Also see all insider trading activities at Gemphire Therapeutics Inc..
Note that in the past
LICHTINGER PEDRO also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Asterias Biotherapeutics, Inc. (AST) by Lichtinger Pedro
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | AST | 128,205 | $499,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Optimer Pharmaceuticals Inc (OPTR) by Lichtinger Pedro
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | OPTR | 0 | $0 | 148,000 | $2,172,344 | 148,000 | $1,844,080 |
| 2012 | OPTR | 11,000 | $99,847 | 0 | $0 | 0 | $0 |
| 2011 | OPTR | 25,000 | $224,450 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Gemphire Therapeutics Inc. (GEMP) by Lichtinger Pedro
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | GEMP | 10,559 | $99,993 | 0 | $0 | 0 | $0 |
| 2016 | GEMP | 10,000 | $100,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lineage Cell Therapeutics, Inc. (BTX) by Lichtinger Pedro
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | BTX | 120,000 | $0 | 0 | $0 | 0 | $0 |
| 2012 | BTX | 6,250 | $24,850 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Lichtinger Pedro:
1. Asterias Biotherapeutics, Inc. (AST)
2. Optimer Pharmaceuticals Inc (OPTR)
3. Gemphire Therapeutics Inc. (GEMP)
4. Lineage Cell Therapeutics, Inc. (BTX)
Table 1. Insider trading of Asterias Biotherapeutics, Inc. (AST) by Lichtinger Pedro
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-02-09 | AST | Buy | 128,205 | 3.90 | 499,999 |
Table 2. Insider trading of Optimer Pharmaceuticals Inc (OPTR) by Lichtinger Pedro
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-04-08 | OPTR | Sale | 148,000 | 14.68 | 2,172,344 |
| 2013-04-08 | OPTR | Option Ex | 148,000 | 12.46 | 1,844,080 |
| 2012-11-08 | OPTR | Buy | 11,000 | 9.08 | 99,847 |
| 2011-08-04 | OPTR | Buy | 25,000 | 8.98 | 224,450 |
Table 3. Insider trading of Gemphire Therapeutics Inc. (GEMP) by Lichtinger Pedro
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-03-10 | GEMP | Buy | 10,559 | 9.47 | 99,993 |
| 2016-08-10 | GEMP | Buy | 10,000 | 10.00 | 100,000 |
Table 4. Insider trading of Lineage Cell Therapeutics, Inc. (BTX) by Lichtinger Pedro
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-06-04 | BTX | Buy | 120,000 | .00 | 0 |
| 2012-04-11 | BTX | Buy | 6,250 | 3.98 | 24,850 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lichtinger Pedro
(CEO and President of Gemphire Therapeutics Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.